Zantac was once one of the most widely used medications in the world. Also sold under the generic name Ranitidine, Zantac is a heartburn drug sometimes also used for those with ulcers and stomach acid conditions like gastroesophageal reflux disease (GERD). Available to consumers as both prescription drugs and over-the-counter medications, Zantac became one of the most widely prescribed and used drugs in the world.
All of that changed in 2020 when the Food and Drug Administration (FDA) asked companies to stop making and distributing the drug after several smaller recalls in 2019. The reason for the recall is that independent testing found worrisome levels of N-Nitrosodimethylamine (NDMA) contaminating many batches of Ranitidine drugs. NDMA is a known carcinogen that causes otherwise healthy people to develop cancer. What rights do those sickened by the use of this medication have?
Your claim will depend on the condition you develop
The exact compensation rights of somebody sickened by long-term use of contaminated Zantac or generic versions of the drug will depend on what kind of cancer they develop. NDMA has a connection with multiple different forms of cancer, as established in studies on rodents.
It could increase the risk of liver cancer, as well as pulmonary and renal tumors. Anyone who develops stomach cancer, cancer of the intestines, esophageal cancer, bladder cancer, prostate cancer, breast cancer, liver cancer, pancreatic cancer or throat/nasal cancer could potentially have a claim. Even thyroid cancer, leukemia, brain cancer and certain kinds of lymphoma could have a connection to ranitidine or Zantac drugs.
The severity of the cancer and its impact on your life will affect your compensation claim. You can potentially make a claim for the cost of medical care and lost wages. Surviving family members would have the right to similar claims if the cancer claims someone’s life.
Zantac is one of many drugs that may do more harm than good
It is hard to know how long widespread contamination of Zantac drugs occurred before the FDA took action. MDMA is a chemical byproduct of the process involved in making the active compounds in Zantac.
Cutting corners in testing and manufacturing processes may have contributed to contamination risks in recent years. It may also be possible that the drug has had contamination issues for decades. Consumers who weren’t aware of those risks could have long-term financial consequences. Those dealing with an unexpected cancer diagnosis who also used Zantac regularly may want to explore if they have grounds for a claim.